Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 21, 2021 - Issue 2
Submit an article Journal homepage
599
Views
8
CrossRef citations to date
0
Altmetric
Systematic review

The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review

Zhen Ruana State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, ChinaView further author information
,
Lisong Yanga State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, ChinaView further author information
,
Honghao Shia State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, ChinaView further author information
,
Xiaomeng Yueb Pharmacy Practice & Administrative Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USAView further author information
,
Yao Wanga State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, ChinaView further author information
,
Miaoying Liangc International Health Management, Imperial College Business School, Imperial College London, London, UKView further author information
&
Hao Hua State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 221-233 | Received 16 Oct 2020, Accepted 02 Dec 2020, Published online: 12 Jan 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zhen Ruan, Yixuan Jiang, Honghao Shi, Ruxu Jia, Carolina Oi Lam Ung & Hao Hu. (2023) Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review. Expert Review of Clinical Pharmacology 16:2, pages 161-176.
Read now
Zhen Ruan, Huimin Zou, Qing Lei, Carolina Oi Lam Ung, Honghao Shi & Hao Hu. (2022) Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review. Expert Review of Pharmacoeconomics & Outcomes Research 22:4, pages 555-574.
Read now

Articles from other publishers (6)

Adie Viljoen, Barrie Chubb, Samuel J. P. Malkin, Sasha Berry, Barnaby Hunt & Stephen C. Bain. (2022) The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK. The European Journal of Health Economics 24:6, pages 895-907.
Crossref
Zach Krauss, Alexandra Hintz & Rebecca Fisk. (2023) Tirzepatide: Clinical review of the “twincretin” injectable. American Journal of Health-System Pharmacy 80:14, pages 879-888.
Crossref
William J. Valentine, Meredith Hoog, Reema Mody, Mark Belger & Richard Pollock. (2023) Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States . Diabetes, Obesity and Metabolism 25:5, pages 1292-1300.
Crossref
Lu Ying, Duan Wei & Luo Xiaoqi. (2023) IMPACTS OF AEROBIC EXERCISE ON CARDIOVASCULAR HEALTH IN COLLEGE STUDENTS. Revista Brasileira de Medicina do Esporte 29.
Crossref
Lei Liu, Zhen Ruan, Carolina Oi Lam Ung, Yawen Zhang, Yang Shen, Sheng Han, Ruxu Jia, Jingtao Qiao, Hao Hu & Lixin Guo. (2022) Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China. Diabetes Therapy 14:1, pages 93-107.
Crossref
Zhen Ruan, Carolina Oi Lam Ung, Yang Shen, Yawen Zhang, Weihao Wang, Jingyi Luo, Huimin Zou, Yan Xue, Yao Wang, Hao Hu & Lixin Guo. (2022) Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China. Diabetes Therapy 13:10, pages 1737-1753.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.